Deoxynivalenol (DON), one of the most common mycotoxins
contaminating
food and feed, has been shown to induce hepatotoxicity. Lactoferrin
(LF) enriched in human milk is a critical functional food component
and performs the hepatoprotection function. Here, we aimed to explore
whether dietary LF supplementation can protect from DON-induced hepatotoxicity
and uncover the underlying mechanism in mice and alpha mouse liver
12 (AML12) hepatocytes. In vivo results revealed
that LF alleviated DON-induced liver injury, reflected by repairing
the hepatic histomorphology and decreasing the plasma alanine aminotransferase
(ALT) level and the number of blood white blood cells (WBC) and neutrophils
(Neu). Moreover, LF decreased the hepatic reactive oxygen species
(ROS) and malondialdehyde (MDA) accumulation and enhanced the hepatic
GSH-px activity and protein expression of Nrf2 and GPX4 to reverse
the DON-induced hepatic oxidative stress. Furthermore, LF downregulated
the pro-inflammatory-response-related gene expressions (IL1β, TNFα, and Tlr4) and the
phosphorylation levels of IKK, IκBα, and p38 in the liver
of DON-exposed mice. Additionally, in vitro studies
confirmed that LF ameliorated the DON-induced oxidation–reduction
imbalance, inflammatory responses, and associated core modulators
of the Nrf2 and MAPK pathways in DON-induced hepatotoxicity. In conclusion,
LF performs hepatic antioxidative and anti-inflammatory functions
by regulating the Nrf2/MAPK signaling pathways, thus reducing DON-induced
hepatotoxicity.